RxDoctor Payments DataLook up a doctor →

Laurianne Scott, DO

Obstetrics & Gynecology · Lancaster, OHNPI 1538132139

Payments from drug & device makers

$37,799in general payments, 2019–2025

Across 561 payments — averaging $67.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$31K
  • Astellas Pharma US Inc$859
  • Novo Nordisk$775
  • Corcept Therapeutics$449
  • Pfizer$376
  • Amgen$358
  • plus $4K from 36 others

What the payments were for

  • Speaking & faculty fees$24,20064%
  • Travel & lodging$4,09811%
  • Food & beverage$9,13924%
  • Education$3631%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,799 in reported general payments places this provider in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.

See all obstetrics & gynecology providers in Ohio

Medicare billing

Part B allowed, 2024
$15,643
Medicare patients
90
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DivigelEstradiol13$2,154
ProgesteroneProgesterone, Micronized33$1,158
Estradiol15$1,064
Raloxifene Hcl14$636
Oxybutynin Chloride ErOxybutynin Chloride17$248

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Vertical Pharmaceuticals, LLCDivigel$87$2,15413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,376 obstetrics & gynecology providers in Ohio.

Other obstetrics & gynecology in Lancaster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →